417 related articles for article (PubMed ID: 12963636)
21. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.
Xiao RP
Sci STKE; 2001 Oct; 2001(104):re15. PubMed ID: 11604549
[TBL] [Abstract][Full Text] [Related]
22. CaMKII-mediated increased lusitropic responses to beta-adrenoreceptor stimulation in ANP-receptor deficient mice.
Yurukova S; Kilić A; Völker K; Leineweber K; Dybkova N; Maier LS; Brodde OE; Kuhn M
Cardiovasc Res; 2007 Mar; 73(4):678-88. PubMed ID: 17107670
[TBL] [Abstract][Full Text] [Related]
23. Adrenergic pathways and left ventricular remodeling.
Dorn GW
J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
[TBL] [Abstract][Full Text] [Related]
24. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
[TBL] [Abstract][Full Text] [Related]
25. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of protein kinase C alpha improves myocardial beta-adrenergic receptor signaling and ventricular function in a model of myocardial preservation.
D'Souza KM; Petrashevskaya NN; Merrill WH; Akhter SA
J Thorac Cardiovasc Surg; 2008 Jan; 135(1):172-9, 179.e1. PubMed ID: 18179937
[TBL] [Abstract][Full Text] [Related]
27. Doxycycline attenuates isoproterenol- and transverse aortic banding-induced cardiac hypertrophy in mice.
Errami M; Galindo CL; Tassa AT; Dimaio JM; Hill JA; Garner HR
J Pharmacol Exp Ther; 2008 Mar; 324(3):1196-203. PubMed ID: 18089841
[TBL] [Abstract][Full Text] [Related]
28. Chronic beta-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart.
Dostanic S; Servant N; Wang C; Chalifour LE
Can J Physiol Pharmacol; 2004 Mar; 82(3):167-74. PubMed ID: 15052282
[TBL] [Abstract][Full Text] [Related]
29. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
[TBL] [Abstract][Full Text] [Related]
30. Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation.
Engelhardt S; Hein L; Dyachenkow V; Kranias EG; Isenberg G; Lohse MJ
Circulation; 2004 Mar; 109(9):1154-60. PubMed ID: 14967726
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
[TBL] [Abstract][Full Text] [Related]
32. Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure.
Wang J; Xu N; Feng X; Hou N; Zhang J; Cheng X; Chen Y; Zhang Y; Yang X
Circ Res; 2005 Oct; 97(8):821-8. PubMed ID: 16151019
[TBL] [Abstract][Full Text] [Related]
33. Gelsolin regulates cardiac remodeling after myocardial infarction through DNase I-mediated apoptosis.
Li GH; Shi Y; Chen Y; Sun M; Sader S; Maekawa Y; Arab S; Dawood F; Chen M; De Couto G; Liu Y; Fukuoka M; Yang S; Da Shi M; Kirshenbaum LA; McCulloch CA; Liu P
Circ Res; 2009 Apr; 104(7):896-904. PubMed ID: 19246681
[TBL] [Abstract][Full Text] [Related]
34. Phosphoinositide 3-kinase gamma regulates cardiac contractility by locally controlling cyclic adenosine monophosphate levels.
Kerfant BG; Rose RA; Sun H; Backx PH
Trends Cardiovasc Med; 2006 Oct; 16(7):250-6. PubMed ID: 16980183
[TBL] [Abstract][Full Text] [Related]
35. Genetic manipulation of myocardial beta-adrenergic receptor activation and desensitization.
Hata JA; Williams ML; Koch WJ
J Mol Cell Cardiol; 2004 Jul; 37(1):11-21. PubMed ID: 15242731
[TBL] [Abstract][Full Text] [Related]
36. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
[TBL] [Abstract][Full Text] [Related]
37. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
Zheng M; Han QD; Xiao RP
Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
[TBL] [Abstract][Full Text] [Related]
38. Increased level of neuronal phosphoinositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception.
Narita M; Imai S; Narita M; Kasukawa A; Yajima Y; Suzuki T
Neuroscience; 2004; 124(3):515-21. PubMed ID: 14980723
[TBL] [Abstract][Full Text] [Related]
39. Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice.
Takeda M; Ito W; Tanabe M; Ueki S; Kato H; Kihara J; Tanigai T; Chiba T; Yamaguchi K; Kayaba H; Imai Y; Okuyama K; Ohno I; Sasaki T; Chihara J
J Allergy Clin Immunol; 2009 Apr; 123(4):805-12. PubMed ID: 19232703
[TBL] [Abstract][Full Text] [Related]
40. β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway.
Vidal M; Wieland T; Lohse MJ; Lorenz K
Cardiovasc Res; 2012 Nov; 96(2):255-64. PubMed ID: 22843704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]